Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2025-12-28 @ 9:48 AM
Study NCT ID:
NCT05845268
Status:
UNKNOWN
Last Update Posted:
2023-05-06
First Post:
2023-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer
Sponsor:
Beijing Friendship Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-30
First Submit QC Date:
None
Study First Post Date:
2023-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-25
Last Update Post Date:
2023-05-06
Last Update Post Date Type:
ACTUAL